|会社名||DaVita Inc （DVA ダヴィ―タ）|
|業種||ヘルスケア施設_サ―ビス 医療関連（Health Care）|
|概要||事業概要 ダヴィータ(DaVita Inc)(旧名: DaVita HealthCare Partners Inc)はDaVita腎臓ケア（腎臓ケア）およびDaVita Medical Group（DMG）2つの事業区分を運営する。腎臓ケア事業は、米国の透析および関連するラボサービス、国際業務を含む付随的なサービス及び戦略的な取り組み、並びに企業の行政支援で構成される。DMG事業は、人権委譲契約を通じて会員に医療サービスを提供する患者と医師を中心とした総合的な医療提供および管理会社である。同社のセグメントは米国の透析と関連ラボサービス、DMG、その他の補助的なサービスと戦略的イニシアチブを含む。米国の透析と関連ラボサービス事業は、米国で、末期腎疾患（ESRD）としても知られている慢性腎不全患者向けに腎臓透析サービスを提供する。同社は154の外来透析センターに管理サービスを提供する。 ダビ―タは米国の医療サ―ビス企業。主に人工透析センタ―のネットワ―クを運営し、外来患者向けの腎臓透析サ―ビスや関連するテストを提供。全米44州とワシントン特別区に約2000カ所の外来透析センタ―を展開。また、米国外の10カ国に73カ所の外来透析センタ―を運営、センタ―の事務管理などのサ―ビスも提供する。本社所在地はコロラド州デンバ―。 DaVita Inc. is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. Through DaVita Kidney Care, the company treats patients with chronic kidney failure and end stage kidney disease. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all. Through these efforts, DaVita has also become the largest provider of home dialysis in the country. As of December 31, 2020, DaVita served 204,200 patients at 2,816 outpatient dialysis centers in the United States. The company also operated 321 outpatient dialysis centers in ten countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere.|
|代表者氏名||Kent J. Thiry|
|代表者役職名||Chairman of the Board Chief Executive Officer|
|決算概要||決算概要 BRIEF: For the fiscal year ended 31 December 2018 Davita Inc revenues increased 5% to $11.4B. Net income before extraordinary items decreased 6% to $616.4M. Revenues reflect Revenue Sales of Goods_Services increase of 6% to $10.71B Provision for uncollectible accounts decrease of 90% to $49.6M. Net income was offset by Dialysis_Related Lab Services segment income decrease of 26% to $1.71B.|
Wall street estimates Earnings report DaVita (NYSE:DVA) 2021/08/02 17:07:00 Stock Market Daily
Earnings results for DaVita , Analyst Opinion on DaVita , Earnings and Valuation of (NYSE:DVA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Wall street estimates Earnings report DaVita (NYSE:DVA) appeared first on .
Toth Financial Advisory Corp Buys ProShares Ultra QQQ, International Business Machines Corp, VF ... 2021/07/26 20:38:20 GuruFocus
Related Stocks: QLD , IBM , VFC , SNOW , UDOW , GVA , UIS , DVA , TBBK , ZS , JAZZ , TGH , TPB , BC , BLD , IBP , PATK , MBUU ,
Employer and Former CEO Indicted in No-Poaching Case 2021/07/21 13:54:47 JD Supra
According to the U.S. Department of Justice (DOJ), on July 15, 2021, DaVita Inc. and its former chief executive officer were accused in an indictment of two counts of violating the Sherman Act, an antitrust law, by conspiring with two competitors to not solicit or hire each others key employees. One of the other companies allegedly part of the arrangement was charged in federal court earlier this year. By: Nexsen Pruet, PLLC
DaVita Inc. Schedules 2nd Quarter 2021 Investor Conference Call 2021/07/21 08:00:00 PR Newswire
DENVER, July 21, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 3, 2021, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
Bank of America Slides After Trading Revenue Slump, $2.2 Billion Reserve Release Saves 2021/07/14 11:50:40 Zero Hedge
Bank of America Slides After Trading Revenue Slump, $2.2 Billion Reserve Release Saves The bank earnings parade continued on Wednesday morning when Bank of America reported disappointing earnings that missed on the top line as a result of disappointing trading revenue like JPM yesterday with FICC sliding 38% Y/Y due to "more benign markets in 2Q21" and badly missing expectations ($1.9BN vs Exp. $2.4BN), but also like JPM beat on the bottom line thanks to an overly generous reserve release. The result in a nutshell: Revenue net of interest expense $21.47 billion, down -3.9% y/y, and missing the estimate of $21.84 billion EPS $1.03 vs. 37c y/y, beating the estimate 77c, and coming above the highest Wall Street forecast of 88c However, unlike JPM which at least reported solid Net Interest Income, BofA was unable to and missed on NII which came in at $10.34BN, below the $10.44BN estimate, hit by lower rates, and down 6% Y/Y while flat sequentially. The Bank''s Net Margin Income dropped to a new record low.
DVA Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Davita Inc (NYSE:DVA) Investors | MarketScreener 2021/02/07 01:53:03 MarketScreener
BOSTON, Feb. 6, 2021 /PRNewswire/ -- Kyros Law Offices is alerting investors of Davita Inc that the deadline in filing claims from the investor lawsuit settlement against the company is fast… | February 7, 2021
Dialysis Market 2021 Size, Industry Share, Growth, Trends And Top Key Players: Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., DaVita Inc., Nipro Corporation 2021/01/29 06:59:56 OpenPR
Allied Market Research recently published a report, titled, the global dialysis market is expected to reach $118.51 billion by 2023 from $91 billion in 2017, registering a CAGR of 4.4% from 2018 to 2023. "Dialysis Market by Type [Hemodialysis (Conventional Hemodialysis,
Hemodialysis And Peritoneal Dialysis Market Future Of Investment Market Share & Trends To 2028 DaVita Healthcare Partners Inc., Baxter International Inc., B. Braun Melsungen AG 2021/01/20 15:57:16 OpenPR
Market Dynamics: With a substantial CAGR over the forecast period, the global demand for hemodialysis and peritoneal dialysis is likely to expand. Based on major segmentations, the main objective of this report is to analyze, identify, identify and assess the global
Renalytix and Davita join forces to identify and manage early-stage kidney disease 2021/01/13 18:00:00 BioWorld
Diagnostics innovator Renalytix AI plc and dialysis giant Davita Inc. partnered to develop a program to identify individuals with early-stage kidney disease and improve outcomes for the 37 million Americans with chronic kidney disease (CKD). The companies plan to launch the collaborative effort in three cities in 2021 to build a diverse, real-world evidence dataset as a base for moving forward.
Global Medical - Social Working Services Market Challenges, Growth, Countries, Revenue & Forecast 2027||Top Companies-Kaiser Permanente; DaVita Inc; Universal Health Services, Inc.; Quest Diagnostics Incorporated 2021/01/08 19:01:26 OpenPR
Data bridge Market research provides a report in which the Medical - Social Working Services market drivers and regulations are derived from a famous SWOT analysis technique. We’ve taken up their organization profiles to really understand those key gamers
関連キーワード （ヘルスケア施設_サ―ビス 米国株 DVA ダヴィ―タ DVA ）